ROBERT KIRK DELISLE,MARK LAURENCE BOYS,MICHAEL F. BRADLEY,DAVID D. HENNINGS,APRIL L. KENNEDY,FREDRIK P. MARMSATER,MATTHEW DAVID MEDINA,MARK C. MUNSON,BRYSON RAST,JAMES P. RIZZI,MARTHA E. RODRIGUEZ,GEO
申请号：
PT10798683
公开号：
PT2516433E
申请日:
2010.12.20
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
